IGC Pharma Inc (IGC)
0.379
+0.01
(+2.99%)
USD |
NYAM |
Dec 20, 16:00
0.3574
-0.02
(-5.70%)
After-Hours: 20:00
IGC Pharma Shareholders Equity (Quarterly): 7.377M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Protalix BioTherapeutics Inc | 32.44M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.37M |
| Total Liabilities (Quarterly) | 2.992M |
| Debt to Equity Ratio | 0.0183 |
| Current Ratio | 1.517 |
| Net Debt Paydown Yield | 0.00% |